CVE-2002-2379

Description

Cisco AS5350 IOS 12.2(11)T with access control lists (ACLs) applied and possibly with ssh running allows remote attackers to cause a denial of service (crash) via a port scan, possibly due to an ssh bug. NOTE: this issue could not be reproduced by the vendor

Category

7.8
CVSS
Severity: High
CVSS 2.0 •
EPSS 19.32% Top 5%
Vendor Advisory cisco.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.cisco.com/en/US/products/hw/univgate/ps501/products_security_notice09186a008024dba2.html vendor advisory
http://cert.uni-stuttgart.de/archive/bugtraq/2002/10/msg00413.html mailing list
http://cert.uni-stuttgart.de/archive/bugtraq/2002/10/msg00420.html mailing list
http://cert.uni-stuttgart.de/archive/bugtraq/2002/10/msg00411.html mailing list
http://cert.uni-stuttgart.de/archive/bugtraq/2002/10/msg00397.html mailing list
http://www.iss.net/security_center/static/10522.php vdb entry
http://www.securityfocus.com/bid/6059 vdb entry

Frequently Asked Questions

What is the severity of CVE-2002-2379?
CVE-2002-2379 has been scored as a high severity vulnerability.
How to fix CVE-2002-2379?
To fix CVE-2002-2379, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2002-2379 being actively exploited in the wild?
It is possible that CVE-2002-2379 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~19% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.